IFP Advisors’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
SS
AWM
FA
FFA
PWA
BWL
SWIM
EWA
IFP Advisors's TXMD Position: Q2 2026 in Review
IFP Advisors held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 21 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #5032.
IFP Advisors first reported a position in TXMD in Q2 2016 and has held it in 23 quarters since. The position peaked at $47K in Q1 2017. 9 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.
- IFP Advisors held 21 shares of TherapeuticsMD worth $46 as of Q2 2026.
- IFP Advisors left its TherapeuticsMD share count unchanged in Q2 2026.
- TherapeuticsMD made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5032 holding.
- IFP Advisors first reported a position in TherapeuticsMD in Q2 2016 and has held it in 23 quarters since.
- IFP Advisors's TherapeuticsMD position peaked at $47K in Q1 2017.
- 9 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.